FINRA. If applicable, FINRA shall have raised no objection to the terms of this offering and the amount of compensation allowable or payable to the Agent as described in the Prospectus.
Appears in 310 contracts
Sources: Atm Sales Agreement (Vision Marine Technologies Inc.), Sales Agreement (Sky Quarry Inc.), Sales Agreement (Brera Holdings PLC)
FINRA. If applicable, FINRA shall have raised no objection to the terms of this the offering contemplated hereby and the amount of compensation allowable or payable to the Agent as described in the Prospectus.
Appears in 126 contracts
Sources: Sales Agreement (Shattuck Labs, Inc.), Sales Agreement (Radiopharm Theranostics LTD), Sales Agreement (Pyxis Oncology, Inc.)
FINRA. If applicable, FINRA shall have raised no objection to the terms of this offering and the amount of compensation allowable or payable to the Agent as described in the Prospectus.
Appears in 94 contracts
Sources: Capital on Demand Sales Agreement (Armata Pharmaceuticals, Inc.), Sales Agreement (Erayak Power Solution Group Inc.), Controlled Equity Offering Sales Agreement (Verastem, Inc.)
FINRA. If applicable, FINRA shall have raised no objection to the terms of this offering and the amount of compensation allowable or payable to the Agent Agents as described in the Prospectus.
Appears in 87 contracts
Sources: Sales Agreement (Bakkt Holdings, Inc.), Sales Agreement (Riot Platforms, Inc.), Sales Agreement (Strive, Inc.)
FINRA. If applicable, FINRA shall have raised no objection to the terms of this offering and the amount of compensation allowable or payable to the Agent ▇▇▇▇▇ as described in the Prospectus.
Appears in 20 contracts
Sources: Sales Agreement (Allogene Therapeutics, Inc.), Sales Agreement (Syndax Pharmaceuticals Inc), Sales Agreement (Syndax Pharmaceuticals Inc)
FINRA. If applicable, FINRA shall have raised no objection to the terms of this offering and the amount of compensation allowable or payable to the Agent Agents as described in the Prospectus.
Appears in 14 contracts
Sources: Sales Agreement (Siebert Financial Corp), Sales Agreement (Bridger Aerospace Group Holdings, Inc.), Sales Agreement (Bridger Aerospace Group Holdings, Inc.)
FINRA. If applicable, FINRA shall have raised no objection to the terms of this the offering contemplated hereby and the amount of compensation allowable or payable to the Agent Agents as described in the Prospectus.
Appears in 13 contracts
Sources: Sales Agreement (Compass Therapeutics, Inc.), Sales Agreement (Structure Therapeutics Inc.), Sales Agreement (Rapport Therapeutics, Inc.)
FINRA. If applicable, FINRA shall not have raised no any objection to the terms of this offering and the amount of compensation allowable or payable to the Agent Agents as described in the U.S. Prospectus.
Appears in 6 contracts
Sources: Sales Agreement (SOL Strategies Inc.), Sales Agreement (Avino Silver & Gold Mines LTD), Sales Agreement (Seabridge Gold Inc)
FINRA. If applicable, FINRA shall not have raised no any objection to the terms of this offering and the amount of compensation allowable or payable to the Agent Agents as described in the Prospectus.
Appears in 5 contracts
Sources: Sales Agreement (Energy Fuels Inc), Sales Agreement (Energy Fuels Inc), Sales Agreement (Avino Silver & Gold Mines LTD)
FINRA. If applicable, FINRA shall have raised no objection to the terms of this offering and the amount of compensation allowable or payable to the Agent as described in the ProspectusProspectuses.
Appears in 4 contracts
Sources: Sales Agreement (Correvio Pharma Corp.), Sales Agreement (Aptose Biosciences Inc.), Sales Agreement (Aurinia Pharmaceuticals Inc.)
FINRA. If applicable, FINRA shall have raised no objection to the terms of this offering and the amount of compensation allowable or payable to the Agent as described in the Prospectus.
Appears in 2 contracts
Sources: At Market Issuance Sales Agreement (NORDIC AMERICAN TANKERS LTD), At Market Issuance Sales Agreement (NORDIC AMERICAN TANKERS LTD)
FINRA. If applicable, FINRA shall not have raised no any objection to the terms of this offering and the amount of compensation allowable or payable to the Agent as described in the U.S. Prospectus.
Appears in 2 contracts
Sources: Sales Agreement (Avino Silver & Gold Mines LTD), Sales Agreement (Energy Fuels Inc)
FINRA. If applicable, FINRA shall have raised no objection to the terms of this offering and the amount of compensation allowable or payable to the Agent ▇▇▇▇▇ as described in the Prospectus.
Appears in 2 contracts
Sources: Sales Agreement (Dermira, Inc.), Sales Agreement (Dermira, Inc.)
FINRA. If applicablethe offering is required to be filed with FINRA, FINRA shall have raised no objection to the terms of this the offering contemplated hereby and the amount of compensation allowable or payable to the Agent as described in the Prospectus.
Appears in 2 contracts
Sources: Sales Agreement (Axsome Therapeutics, Inc.), Sales Agreement (Axsome Therapeutics, Inc.)
FINRA. If applicable, FINRA shall have raised no objection to the terms of this offering and the amount of compensation allowable or payable to the Sales Agent as described in the Prospectus.
Appears in 2 contracts
Sources: At the Market Issuance Sales Agreement (Haoxi Health Technology LTD), At the Market Issuance Sales Agreement (Innovation Beverage Group LTD)
FINRA. If applicable, FINRA shall not have raised no any objection to the terms of this offering and the amount of compensation allowable or payable to the Agent as described in the Prospectus.
Appears in 2 contracts
Sources: Sales Agreement (Avino Silver & Gold Mines LTD), Sales Agreement (Avino Silver & Gold Mines LTD)
FINRA. If applicable, FINRA shall have raised no objection to the terms of this offering the Offering and the amount of compensation allowable or payable to the Placement Agent as described in the ProspectusProspectus Supplement.
Appears in 1 contract
Sources: Placement Agency Agreement (Galera Therapeutics, Inc.)
FINRA. If applicable, FINRA shall not have raised no any objection to the terms of this offering and the amount of compensation allowable or payable to the Agent as described in the Prospectus.
Appears in 1 contract
Sources: Sales Agreement (Energy Fuels Inc)
FINRA. If applicable, FINRA shall have raised no objection to the terms of this the offering contemplated hereby and the amount of compensation allowable or payable to the Agent as described in the ATM Prospectus.
Appears in 1 contract
FINRA. If applicable, FINRA shall have raised no objection to the terms of this offering and the amount of compensation allowable or payable to the Agent as described in the Prospectus.;
Appears in 1 contract
FINRA. If applicable, FINRA shall have raised no objection to the terms of this the offering contemplated hereby and the amount of compensation allowable or payable to the Agent as described in the Prospectus.
Appears in 1 contract
Sources: Sales Agreement (Quantum-Si Inc)
FINRA. If applicable, FINRA shall have raised no objection to the terms of this the offering contemplated hereby and the amount of compensation allowable or payable to the Agent as described in the Prospectus, or the offering shall be otherwise exempt from filing with FINRA under FINRA Rule 5110(h)(1).
Appears in 1 contract
Sources: Sales Agreement (Adagene Inc.)
FINRA. If applicable, FINRA shall have raised no objection to the terms of this the offering contemplated hereby and the amount of compensation allowable or payable to the Agent as described in the ProspectusProspectuses.
Appears in 1 contract
FINRA. If applicable, FINRA shall have raised no objection objections to the terms of this offering and the amount of compensation allowable or payable to the Agent as described in the Prospectus.
Appears in 1 contract
FINRA. If applicable, FINRA shall have raised no objection to the terms of this the offering contemplated hereby and the amount of compensation allowable or payable to the Agent as described in the Prospectus.. #98069312v14 302805643 v12
Appears in 1 contract
Sources: Sales Agreement (Oculis Holding AG)
FINRA. If applicable, FINRA shall not have raised no any objection to the terms of this offering and the amount of compensation allowable or payable to the Agent Agents as described in the U.S. Prospectus.
Appears in 1 contract